A.R.T. Advisors, LLC - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$918,000
+1.7%
43,836
+16.2%
0.05%
-20.7%
Q4 2018$903,000
+284.3%
37,734
+337.0%
0.06%
+427.3%
Q3 2018$235,000
-68.6%
8,634
-69.0%
0.01%
-63.3%
Q2 2018$748,000
+264.9%
27,834
+411.7%
0.03%
+233.3%
Q4 2017$205,0005,4400.01%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders